Kelly Financial Services’s Zomedica Corp. ZOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,500
Closed -$219 793
2024
Q2
$219 Hold
1,500
﹤0.01% 737
2024
Q1
$219 Hold
1,500
﹤0.01% 749
2023
Q4
$300 Hold
1,500
﹤0.01% 729
2023
Q3
$251 Hold
1,500
﹤0.01% 717
2023
Q2
$300 Hold
1,500
﹤0.01% 676
2023
Q1
$318 Hold
1,500
﹤0.01% 654
2022
Q4
$245 Hold
1,500
﹤0.01% 635
2022
Q3
$317 Hold
1,500
﹤0.01% 637
2022
Q2
$330 Hold
1,500
﹤0.01% 624
2022
Q1
$506 Hold
1,500
﹤0.01% 609
2021
Q4
$460 Hold
1,500
﹤0.01% 629
2021
Q3
$785 Hold
1,500
﹤0.01% 578
2021
Q2
$1.25K Hold
1,500
﹤0.01% 545
2021
Q1
$2.37K Buy
+1,500
New +$2.45K ﹤0.01% 487

Other funds holding ZOM

Kelly Financial Services's ZOM Position: Q3 2024 in Review

Kelly Financial Services sold out of Zomedica Corp. (ZOM) in Q3 2024, closing a stake of 1,500 shares — an estimated $219 sold.

Kelly Financial Services first reported a position in ZOM in Q1 2021 and held it in 14 quarters. The position peaked at $2.37K in Q1 2021. 85 funds tracked by Wall St. Rank hold ZOM as of Q3 2024.

  • Kelly Financial Services reported no remaining Zomedica Corp. position as of Q3 2024 after selling out during the quarter.
  • Kelly Financial Services sold 1,500 Zomedica Corp. shares in Q3 2024, an estimated $219.
  • Kelly Financial Services first reported a position in Zomedica Corp. in Q1 2021 and held it in 14 quarters.
  • Kelly Financial Services's Zomedica Corp. position peaked at $2.37K in Q1 2021.
  • 85 funds tracked by Wall St. Rank held Zomedica Corp. as of Q3 2024.

Based on Kelly Financial Services's 13F filing for Q3 2024, filed 9 Oct 2024.